• Profile
Close

Worse survival after curative resection in patients with pathological stage I non-small cell lung cancer adjoining pulmonary cavity formation

Journal of Thoracic Disease Oct 02, 2017

Kimura H, et al. - A link between lung cancer and pulmonary cavity has been observed by a few investigators. This study intended to shed light on the clinical features and associated survival outcomes following curative surgery in patients with early non-small cell lung cancer (NSCLC) adjoining pulmonary cavity formation. Findings indicated that surgical resection afforded an increased risk of poor overall survival (OS) and recurrence-free survival (RFS) in patients with early-stage NSCLC adjoining pulmonary cavity formation.

Methods

  • A retrospective review was performed in 275 patients with pathological stage I NSCLC by re-evaluating their chest computed tomography images.
  • Among them, researchers detected NSCLC adjoining pulmonary cavity formation in 12 (4.4%) patients.

Results

  • 43.2 (range, 6.0–86.0) months was the median follow-up period for all 275 patients.
  • Data reported that among these patients, 6 (50.0%) in group CF (patients with NSCLC adjoining pulmonary cavity formation) and 19 (7.2%) in group C (the control group, n=263) died during the study period.
  • Recurrence of the primary lung cancer was seen in 6 (50.0%) and 32 (12.2%) patients in groups CF and C, respectively.
  • At 5 years, in groups CF and C, cumulative overall survival (OS) was 37.0% and 91.7%, respectively (P<0.0001) and, recurrence-free survival (RFS) was 55.0% and 86.7%, respectively (P=0.001).
  • An association of male sex, smoking habits, non-adenocarcinoma, and presence of pulmonary cavity formation with poor OS (P=0.008, P=0.001, P<0.0001, and P<0.0001, respectively) was revealed in univariate analysis.
  • Additionally, it was evident in multivariate analysis that smoking, non-adenocarcinoma, and pulmonary cavity formation were independent prognostic factors predicting poor survival (P=0.043, P=0.004 and P<0.0001, respectively).

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay